1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Self-administered Drugs Consumption 2016-2026
2.1.2 Self-administered Drugs Consumption CAGR by Region
2.2 Self-administered Drugs Segment by Type
2.2.1 Injectable Drugs
2.2.2 Inhaled Drugs
2.2.3 Transdermal Drugs
2.3 Self-administered Drugs Sales by Type
2.3.1 Global Self-administered Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Self-administered Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Self-administered Drugs Sale Price by Type (2016-2021)
2.4 Self-administered Drugs Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Diabetes
2.4.3 Osteoporosis
2.4.4 Pain Management
2.4.5 Hormone Replacement
2.4.6 Others
2.5 Self-administered Drugs Sales by Application
2.5.1 Global Self-administered Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Self-administered Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Self-administered Drugs Sale Price by Application (2016-2021)
3 Global Self-administered Drugs by Company
3.1 Global Self-administered Drugs Sales Market Share by Company
3.1.1 Global Self-administered Drugs Sales by Company (2019-2021)
3.1.2 Global Self-administered Drugs Sales Market Share by Company (2019-2021)
3.2 Global Self-administered Drugs Revenue Market Share by Company
3.2.1 Global Self-administered Drugs Revenue by Company (2019-2021)
3.2.2 Global Self-administered Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Self-administered Drugs Sale Price by Company
3.4 Global Manufacturers Self-administered Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Self-administered Drugs Product Location Distribution
3.4.2 Players Self-administered Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Self-administered Drugs by Region
4.1 Global Self-administered Drugs by Region
4.1.1 Global Self-administered Drugs Sales by Region
4.1.2 Global Self-administered Drugs Revenue by Region
4.2 Americas Self-administered Drugs Sales Growth
4.3 APAC Self-administered Drugs Sales Growth
4.4 Europe Self-administered Drugs Sales Growth
4.5 Middle East & Africa Self-administered Drugs Sales Growth
5 Americas
5.1 Americas Self-administered Drugs Sales by Country
5.1.1 Americas Self-administered Drugs Sales by Country (2016-2021)
5.1.2 Americas Self-administered Drugs Revenue by Country (2016-2021)
5.2 Americas Self-administered Drugs Sales by Type
5.3 Americas Self-administered Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Self-administered Drugs Sales by Region
6.1.1 APAC Self-administered Drugs Sales by Region (2016-2021)
6.1.2 APAC Self-administered Drugs Revenue by Region (2016-2021)
6.2 APAC Self-administered Drugs Sales by Type
6.3 APAC Self-administered Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Self-administered Drugs by Country
7.1.1 Europe Self-administered Drugs Sales by Country (2016-2021)
7.1.2 Europe Self-administered Drugs Revenue by Country (2016-2021)
7.2 Europe Self-administered Drugs Sales by Type
7.3 Europe Self-administered Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Self-administered Drugs by Country
8.1.1 Middle East & Africa Self-administered Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Self-administered Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Self-administered Drugs Sales by Type
8.3 Middle East & Africa Self-administered Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Self-administered Drugs Distributors
10.3 Self-administered Drugs Customer
11 Global Self-administered Drugs Market Forecast
11.1 Global Self-administered Drugs Forecast by Region
11.1.1 Global Self-administered Drugs Forecast by Regions (2021-2026)
11.2.2 Global Self-administered Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Self-administered Drugs Forecast by Type
11.7 Global Self-administered Drugs Forecast by Application
12 Key Players Analysis
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Abbott Laboratories Company Information
12.1.2 Abbott Laboratories Self-administered Drugs Product Offered
12.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Abbott Laboratories Main Business Overview
12.1.5 Abbott Laboratories Latest Developments
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Information
12.2.2 Bristol-Myers Squibb Self-administered Drugs Product Offered
12.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Bristol-Myers Squibb Main Business Overview
12.2.5 Bristol-Myers Squibb Latest Developments
12.3 Novartis AG
12.3.1 Novartis AG Company Information
12.3.2 Novartis AG Self-administered Drugs Product Offered
12.3.3 Novartis AG Self-administered Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis AG Main Business Overview
12.3.5 Novartis AG Latest Developments
12.4 Eli Lilly and Company
12.4.1 Eli Lilly and Company Company Information
12.4.2 Eli Lilly and Company Self-administered Drugs Product Offered
12.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Eli Lilly and Company Main Business Overview
12.4.5 Eli Lilly and Company Latest Developments
12.5 Gilead Sciences
12.5.1 Gilead Sciences Company Information
12.5.2 Gilead Sciences Self-administered Drugs Product Offered
12.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Gilead Sciences Main Business Overview
12.5.5 Gilead Sciences Latest Developments
12.6 Antares Pharma
12.6.1 Antares Pharma Company Information
12.6.2 Antares Pharma Self-administered Drugs Product Offered
12.6.3 Antares Pharma Self-administered Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Antares Pharma Main Business Overview
12.6.5 Antares Pharma Latest Developments
…
13 Research Findings and Conclusion
List of TablesTable 1. Self-administered Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Injectable Drugs
Table 3. Major Players of Inhaled Drugs
Table 4. Major Players of Transdermal Drugs
Table 5. Global Self-administered Drugs Sales by Type (2016-2021) & (K MT)
Table 6. Global Self-administered Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Self-administered Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Self-administered Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Self-administered Drugs Sale Price by Type (2016-2021)
Table 10. Global Self-administered Drugs Sales by Application (2016-2021) & (K MT)
Table 11. Global Self-administered Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Self-administered Drugs Value by Application (2016-2021)
Table 13. Global Self-administered Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Self-administered Drugs Sale Price by Application (2016-2021)
Table 15. Global Self-administered Drugs Sales by Company (2019-2021) & (K MT)
Table 16. Global Self-administered Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Self-administered Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Self-administered Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Self-administered Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Self-administered Drugs Producing Area Distribution and Sales Area
Table 21. Players Self-administered Drugs Products Offered
Table 22. Self-administered Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Self-administered Drugs Sales by Region (2016-2021) (K MT)
Table 26. Global Self-administered Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Self-administered Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Self-administered Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Self-administered Drugs Sales by Country (2016-2021) & (K MT)
Table 30. Americas Self-administered Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Self-administered Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Self-administered Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Self-administered Drugs Sales by Type (2016-2021) & (K MT)
Table 34. Americas Self-administered Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Self-administered Drugs Sales by Application (2016-2021) & (K MT)
Table 36. Americas Self-administered Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Self-administered Drugs Sales by Region (2016-2021) & (K MT)
Table 38. APAC Self-administered Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Self-administered Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Self-administered Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Self-administered Drugs Sales by Type (2016-2021) & (K MT)
Table 42. APAC Self-administered Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Self-administered Drugs Sales by Application (2016-2021) & (K MT)
Table 44. APAC Self-administered Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Self-administered Drugs Sales by Country (2016-2021) & (K MT)
Table 46. Europe Self-administered Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Self-administered Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Self-administered Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Self-administered Drugs Sales by Type (2016-2021) & (K MT)
Table 50. Europe Self-administered Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Self-administered Drugs Sales by Application (2016-2021) & (K MT)
Table 52. Europe Self-administered Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Self-administered Drugs Sales by Country (2016-2021) & (K MT)
Table 54. Middle East & Africa Self-administered Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Self-administered Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Self-administered Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Self-administered Drugs Sales by Type (2016-2021) & (K MT)
Table 58. Middle East & Africa Self-administered Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Self-administered Drugs Sales by Application (2016-2021) & (K MT)
Table 60. Middle East & Africa Self-administered Drugs Sales Market Share by Application (2016-2021)
Table 61. Global Self-administered Drugs Sales Forecast by Type (2021-2026) & (K MT)
Table 62. Global Self-administered Drugs Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Self-administered Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Self-administered Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Self-administered Drugs Sales Forecast by Application (2021-2026) & (K MT)
Table 66. Global Self-administered Drugs Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Self-administered Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Self-administered Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 69. Abbott Laboratories Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 70. Abbott Laboratories Self-administered Drugs Product Offered
Table 71. Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 72. Abbott Laboratories Main Business
Table 73. Abbott Laboratories Latest Developments
Table 74. Bristol-Myers Squibb Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Bristol-Myers Squibb Self-administered Drugs Product Offered
Table 76. Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 77. Bristol-Myers Squibb Main Business
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Novartis AG Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis AG Self-administered Drugs Product Offered
Table 81. Novartis AG Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 82. Novartis AG Main Business
Table 83. Novartis AG Latest Developments
Table 84. Eli Lilly and Company Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Eli Lilly and Company Self-administered Drugs Product Offered
Table 86. Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 87. Eli Lilly and Company Main Business
Table 88. Eli Lilly and Company Latest Developments
Table 89. Gilead Sciences Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Gilead Sciences Self-administered Drugs Product Offered
Table 91. Gilead Sciences Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 92. Gilead Sciences Main Business
Table 93. Gilead Sciences Latest Developments
Table 94. Antares Pharma Basic Information, Self-administered Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Antares Pharma Self-administered Drugs Product Offered
Table 96. Antares Pharma Self-administered Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 97. Antares Pharma Main Business
Table 98. Antares Pharma Latest Developments
List of Figures
Figure 1. Picture of Self-administered Drugs
Figure 2. Self-administered Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Self-administered Drugs Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Self-administered Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Self-administered Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Injectable Drugs
Figure 10. Product Picture of Inhaled Drugs
Figure 11. Product Picture of Transdermal Drugs
Figure 12. Global Self-administered Drugs Sales Market Share by Type in 2020
Figure 13. Global Self-administered Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Self-administered Drugs Consumed in Cardiovascular Diseases
Figure 15. Global Self-administered Drugs Market: Cardiovascular Diseases (2016-2021) & (K MT)
Figure 16. Self-administered Drugs Consumed in Diabetes
Figure 17. Global Self-administered Drugs Market: Diabetes (2016-2021) & (K MT)
Figure 18. Self-administered Drugs Consumed in Osteoporosis
Figure 19. Global Self-administered Drugs Market: Osteoporosis (2016-2021) & (K MT)
Figure 20. Self-administered Drugs Consumed in Pain Management
Figure 21. Global Self-administered Drugs Market: Pain Management (2016-2021) & (K MT)
Figure 22. Self-administered Drugs Consumed in Hormone Replacement
Figure 23. Global Self-administered Drugs Market: Hormone Replacement (2016-2021) & (K MT)
Figure 24. Self-administered Drugs Consumed in Others
Figure 25. Global Self-administered Drugs Market: Others (2016-2021) & (K MT)
Figure 26. Global Self-administered Drugs Sales Market Share by Application (2016-2021)
Figure 27. Global Self-administered Drugs Revenue Market Share by Application in 2020
Figure 28. Global Self-administered Drugs Revenue Market by Company in 2020 ($ Million)
Figure 29. Global Self-administered Drugs Revenue Market Share by Company in 2020
Figure 30. Global Self-administered Drugs Sales Market Share by Regions (2016-2021)
Figure 31. Global Self-administered Drugs Revenue Market Share by Region in 2020
Figure 32. Americas Self-administered Drugs Sales 2016-2021 (K MT)
Figure 33. Americas Self-administered Drugs Revenue 2016-2021 ($ Millions)
Figure 34. APAC Self-administered Drugs Sales 2016-2021 (K MT)
Figure 35. APAC Self-administered Drugs Revenue 2016-2021 ($ Millions)
Figure 36. Europe Self-administered Drugs Sales 2016-2021 (K MT)
Figure 37. Europe Self-administered Drugs Revenue 2016-2021 ($ Millions)
Figure 38. Middle East & Africa Self-administered Drugs Sales 2016-2021 (K MT)
Figure 39. Middle East & Africa Self-administered Drugs Revenue 2016-2021 ($ Millions)
Figure 40. Americas Self-administered Drugs Sales Market Share by Country in 2020
Figure 41. Americas Self-administered Drugs Revenue Market Share by Country in 2020
Figure 42. Americas Self-administered Drugs Sales Market Share by Type in 2020
Figure 43. Americas Self-administered Drugs Sales Market Share by Application in 2020
Figure 44. United States Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Canada Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Mexico Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Brazil Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. APAC Self-administered Drugs Sales Market Share by Region in 2020
Figure 49. APAC Self-administered Drugs Revenue Market Share by Regions in 2020
Figure 50. APAC Self-administered Drugs Sales Market Share by Type in 2020
Figure 51. APAC Self-administered Drugs Sales Market Share by Application in 2020
Figure 52. China Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Japan Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Korea Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Southeast Asia Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. India Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Australia Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Europe Self-administered Drugs Sales Market Share by Country in 2020
Figure 59. Europe Self-administered Drugs Revenue Market Share by Country in 2020
Figure 60. Europe Self-administered Drugs Sales Market Share by Type in 2020
Figure 61. Europe Self-administered Drugs Sales Market Share by Application in 2020
Figure 62. Germany Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. France Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. UK Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Italy Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Russia Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Middle East & Africa Self-administered Drugs Sales Market Share by Country in 2020
Figure 68. Middle East & Africa Self-administered Drugs Revenue Market Share by Country in 2020
Figure 69. Middle East & Africa Self-administered Drugs Sales Market Share by Type in 2020
Figure 70. Middle East & Africa Self-administered Drugs Sales Market Share by Application in 2020
Figure 71. Egypt Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. South Africa Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Israel Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. Turkey Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. GCC Country Self-administered Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
